Management and Preventive Measures for Febrile Neutropenia

Area of Science:

• Oncology
• Infectious Diseases
• Hematology

Background:

• Febrile neutropenia (FN) is a life-threatening oncological emergency and common chemotherapy complication.
• In immunocompromised patients, fever can be the sole indicator of infection, necessitating urgent intervention.
• Prompt management of FN is crucial to prevent severe morbidity and mortality.

Purpose of the Study:

• To review the definition and clinical significance of febrile neutropenia.
• To describe available risk assessment tools for stratifying FN patient risk.
• To discuss current treatment and prophylactic antimicrobial strategies for FN.

Main Methods:

• Review of existing literature on febrile neutropenia management.
• Description of risk stratification tools used in clinical practice.
• Discussion of evidence-based treatment and prophylaxis guidelines.

Main Results:

• All patients with FN require immediate broad-spectrum antibiotic coverage.
• Risk assessment scores aid in individualizing treatment intensity and duration.
• Prophylactic antimicrobials are indicated in select high-risk patient populations.

Conclusions:

• Febrile neutropenia demands immediate, universal antibiotic therapy.
• Risk stratification optimizes individualized treatment and prophylactic approaches.
• Effective management of FN relies on timely assessment and tailored antimicrobial strategies.